• English
    X

    Google Translate Disclaimer

    The Maryland Department of Information Technology (“DoIT”) offers translations of the content through Google Translate. Because Google Translate is an external website, DoIT does not control the quality or accuracy of translated content. All DoIT content is filtered through Google Translate which may result in unexpected and unpredictable degradation of portions of text, images and the general appearance on translated pages. Google Translate may maintain unique privacy and use policies. These policies are not controlled by DoIT and are not associated with DoIT’s privacy and use policies. After selecting a translation option, users will be notified that they are leaving DoIT’s website. Users should consult the original English content on DoIT’s website if there are any questions about the translated content.

    DoIT uses Google Translate to provide language translations of its content. Google Translate is a free, automated service that relies on data and technology to provide its translations. The Google Translate feature is provided for informational purposes only. Translations cannot be guaranteed as exact or without the inclusion of incorrect or inappropriate language. Google Translate is a third-party service and site users will be leaving DoIT to utilize translated content. As such, DoIT does not guarantee and does not accept responsibility for, the accuracy, reliability, or performance of this service nor the limitations provided by this service, such as the inability to translate specific files like PDFs and graphics (e.g. .jpgs, .gifs, etc.).

    DoIT provides Google Translate as an online tool for its users, but DoIT does not directly endorse the website or imply that it is the only solution available to users. All site visitors may choose to use alternate tools for their translation needs. Any individuals or parties that use DoIT content in translated form, whether by Google Translate or by any other translation services, do so at their own risk. DoIT is not liable for any loss or damages arising out of, or issues related to, the use of or reliance on translated content. DoIT assumes no liability for any site visitor’s activities in connection with use of the Google Translate functionality or content.

    The Google Translate service is a means by which DoIT offers translations of content and is meant solely for the convenience of non-English speaking users of the website. The translated content is provided directly and dynamically by Google; DoIT has no direct control over the translated content as it appears using this tool. Therefore, in all contexts, the English content, as directly provided by DoIT is to be held authoritative.

    Maryland posts first-quarter 2016 data on fatal overdoses
    Health Secretary urges users of drugs to seek treatment: ‘No illicit drug is safe’
     
    Baltimore, MD (June 29, 2016) – The Department of Health and Mental Hygiene has posted to its website the first-quarter data report for 2016 of fatal overdoses. From January to March, Maryland saw 383 deaths related to overdose. The report is posted at http://goo.gl/XogGSc 
     
    Fighting substance-use disorder and the opioid epidemic in Maryland has been a major priority of Maryland Gov. Larry Hogan’s administration. Earlier this month, Health and Mental Hygiene released the annual report of fatal overdoses from 2015. That report logged a total of 1,259 overdose deaths occurred in Maryland in 2015. The number of intoxication deaths had nearly doubled since 2010.  
     
    In January, Health and Mental Hygiene issued a warning about seeing overdose data that suggested that a portion of the fatal overdoses were attributed to people unknowingly buying fentanyl while attempting to purchase other substances like heroin or cocaine. The department is repeating that concern.  
    “Fentanyl is significantly more potent than heroin and is being added – sometimes secretly – to other drugs. No illicit drug is safe. We need people to choose treatment before their next craving for a high hits,” said Health Secretary Van T. Mitchell. “These overdose data show it is just too easy to die from using drugs today. There’s no other way to read the data.”   
     
    Health and Mental Hygiene has been collaborating with federal, state and local partners to try to reduce the number of overdoses and has been combating and responding to the increase in overdose deaths. With support from Governor Hogan, the department has expanded access to naloxone, a life-saving drug that can reverse opioid-related overdoses. 
     
    In December 2015, a standing order under Deputy Secretary of Public Health Dr. Howard Haft was issued. The order allows all Maryland-licensed pharmacists to dispense naloxone without a prescription to anyone trained and certified under the Department’s Overdose Response Program. Health and Mental Hygiene has authorized 55 organizations to conduct naloxone trainings and to issue certificates, including local health departments, substance-use treatment programs, community organizations and law enforcement agencies. Nearly 23,000 people have been certified by these organizations since the Program was established in March 2014.
     
    The Maryland Good Samaritan Law​ first passed in 2013. It was updated in 2015 to include protection from arrest and expanded the pertinent crimes – such as possession of controlled dangerous substances – and also added that calling 911 would not affect someone's parole and probation status. The Overdose Response Program law and other longtime existing laws protect people who prescribe, dispense, carry and use naloxone.
     
    Because opioid addiction often has its roots in prescribed medication, Health and Mental Hygiene co-sponsored Scope of Pain last fall, a prescriber-education seminar geared toward training providers in managing their patients’ chronic pain in ways to not facilitate addiction to opioids. Clinical provider education and resources continue to be a critical focus of the department’s addiction-prevention strategy, being achieved through Continuing Medical Education and the Prescription Drug Monitoring Program (PDMP). Maryland’s PDMP allows providers and pharmacists access to their patients’ history of prescribed medications. Providers will be required to register with the PDMP this coming October to obtain a Controlled Dangerous Substance permit.
     
    The Department is also expanding access to Screening, Brief Intervention and Referral to Treatment (SBIRT). SBIRT is an evidence-based tool designed to identify individuals who have the potential for substance abuse and to provide medical intervention. It has been implemented in 53 community primary care centers and two hospitals in 15 jurisdictions across Maryland with the expectation of screening at least 90,000 individuals.  
     
    Because people who die from overdoses often have histories of hospitalization for nonfatal overdoses, the department also has been working to intervene in Marylanders’ lives after they survive an overdose. The Overdose Survivors Outreach Program is an initiative to improve health outcomes for overdose survivors or those at risk for overdose by collaborating with hospitals and local health departments to facilitate interventions by Peer Recovery Specialists in the emergency department. If a patient has overdosed, or is at risk for overdose, the peer will work with the patient to assist them in enrolling in treatment or support services. If she or he is not interested in treatment, the peer will obtain consent to refer them to an outreach peer at the local health department, who will contact them via phone or field call a day or two after presenting in the emergency department, and will periodically check in to assess their needs and willingness to enter treatment. As of June 2016, four hospitals in Baltimore City are participating in this program, as are two in northern Anne Arundel County.
     
    Maryland Medicaid also has implemented a Corrective Managed Care program to identify participants who may be utilizing excessive quantities of controlled substances, especially when multiple prescribers and pharmacies are involved. Each month, specific participants are identified, their drug and diagnosis histories are reviewed and a determination is made whether an educational intervention letter should be sent to all prescribers and pharmacies affiliated with those participants. If intervention letters are insufficient and drug utilization does not improve, Medicaid participants can be restricted to a single pharmacy to reduce possible misuse or diversion.    
           
    Marylanders who need help finding substance abuse treatment resources should visit http://goo.gl/nIfGm0 or call the Maryland Crisis Hotline, which provides 24/7 support, at 1-800-422-0009. For information on many of the policies currently implemented to fight addiction and overdose in Maryland, see http://goo.gl/KvEzQw. If you know of someone who could use treatment for substance abuse, treatment facilities can be located by location and program characteristics on our page at http://goo.gl/rbGF6S.   
    ###